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, cities, clinics, subjects) -----------------------------------------------------------------------------
Method of recruitment (e.g., referral, self-selection), including the sampling method if a systematic sampling plan was implemented~: o Exposure quantity and duration: how many sessions or episodes or events were intended to be delivered? How long were they /"
b 17
intended to last? 5 o Time span: how long was it intended to take to deliver the . intervention to each unit?~~/7 
• If the unit of analysis differs from the unit of assignment, the analytical method used to account for this (e.g., adjusting the standard error /'ẽ stimates by the design effect or using multilevel analysis) et;
analyses and adjusted analysis 
o Allocation and intervention exposure: the number of participants assigned to each study condition and the number of participants who received each intervention
-------------------------------------------------------------------------------------------------------------------------------------------------------------
o Follow-up: the number of participants who completed the followup or did not complete the follow-up (I.e., lost to follow-up), by
_____________________________~_~_~y. ___~_!:'_9_~~!.?_~___________________________________________________________________________________________ _ _
o Analysis: the number of participants included in or excluded from / the main analysis, by study condition • Data on study group equivalence at baseline and statistical methods used to control for baseline differences f Ĩ 2.
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Recruitment
• Number of participants (denominator) included in each analysis for each / fP analyzed study condition, particularly when the denominators change for different __~lõ utcomes; statement ofthe results in absolute numbers when feasible
• Indication of whether the analysis strategy was "intention to treat" or, if 
• Inclusion of results from testing pre-specified causal pathways through 
DISCUSSION
Interpretation 20
• Interpretation of the results, taking into account study hypotheses, sources of potential bias, imprecision of measures, multiplicative analyses,
• Discussion of results taking into account the mechanism by which the intervention was intended to work (causal pathways) or alternative
./ \~,- 
